Achieve Life Sciences Inc... (ACHV)
NASDAQ: ACHV
· Real-Time Price · USD
2.54
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:59 PM
2.46
-3.34%
After-hours: Aug 15, 2025, 07:49 PM EDT
Achieve Life Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | 57K | 57K | 57K | 100K | 100K | n/a | 65K | 55K | 56K | 60K | 62K | 61K | 63K | 64K |
Gross Profit | n/a | n/a | n/a | -57K | -57K | -57K | -100K | -100K | n/a | -65K | -55K | -56K | -60K | -62K | -61K | -63K | -64K |
Operating Income | n/a | -12.19M | n/a | -8.46M | -5.98M | -4.39M | -6.57M | -7.71M | -8.58M | -10.86M | -12.6M | -10.06M | -7.23M | -7.12M | -6.69M | -11.31M | -7.98M |
Interest Income | 322K | 482K | 673K | 833K | 368K | 208K | 262K | 193K | 162K | 118K | 73K | 4K | 4K | 3K | 3K | 3K | 8K |
Pretax Income | -12.83M | -12.36M | -12.51M | -8.46M | -6.49M | -5.48M | -7.11M | -8.24M | -8.99M | -11.23M | -13.08M | -10.47M | -7.57M | -7.15M | -6.69M | -11.31M | -8M |
Net Income | -12.83M | -12.36M | -12.51M | -8.46M | -6.49M | -5.48M | -7.11M | -8.24M | -8.99M | -10.99M | -13.56M | -10.87M | -7.92M | -7.15M | -6.69M | -11.31M | -8M |
Selling & General & Admin | 5.8M | 4.89M | 4.86M | 3.32M | 3.13M | 2.21M | 2.99M | 3.13M | 3.04M | 2.25M | 2.77M | 2.87M | 2.84M | 2.61M | 2.1M | 2.08M | 2.34M |
Research & Development | 7.1M | 7.3M | 7.61M | 5.11M | 2.8M | 2.11M | 3.58M | 4.58M | 5.53M | 8.61M | 9.87M | 7.21M | 4.39M | 4.51M | 4.59M | 9.23M | 5.64M |
Other Expenses | n/a | n/a | n/a | -2K | -15K | 17K | -17K | -525K | n/a | n/a | -30K | 5K | 6K | -36K | -1K | -12K | -15K |
Operating Expenses | 12.89M | 12.19M | 12.47M | 8.43M | 5.92M | 4.33M | 6.57M | 7.71M | 8.58M | 10.86M | 12.64M | 10.07M | 7.23M | 7.12M | 6.69M | 11.3M | 7.98M |
Interest Expense | 185K | 197K | 366K | 804K | 813K | 787K | 781K | 712K | 573K | 547K | 481K | 404K | 357K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -57K | -57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 12.36M | 12.47M | 8.43M | 5.98M | 4.39M | 6.57M | 7.71M | 8.58M | 10.86M | 12.64M | 10.07M | 7.23M | 7.12M | 6.69M | 11.3M | 7.98M |
Income Tax Expense | n/a | n/a | n/a | n/a | 13.72K | 13.19K | n/a | -55K | n/a | -242K | 481K | 404K | 347K | 36K | -3K | -3K | -8K |
Shares Outstanding (Basic) | 34.69M | 34.51M | 34.36M | 34.32M | 25.05M | 21.17M | 21.13M | 19.05M | 17.92M | 13.54M | 9.69M | 9.65M | 9.46M | 9.45M | 9.45M | 7.39M | 6.13M |
Shares Outstanding (Diluted) | 34.69M | 34.51M | 34.36M | 34.32M | 25.05M | 21.17M | 21.13M | 19.05M | 17.92M | 13.54M | 9.69M | 9.65M | 9.46M | 9.45M | 9.45M | 7.39M | 6.13M |
EPS (Basic) | -0.37 | -0.39 | -0.36 | -0.25 | -0.26 | -0.26 | -0.34 | -0.43 | -0.5 | -0.81 | -1.4 | -1.13 | -0.84 | -0.76 | -0.71 | -1.53 | -1.3 |
EPS (Diluted) | -0.37 | -0.39 | -0.36 | -0.25 | -0.26 | -0.26 | -0.34 | -0.43 | -0.5 | -0.81 | -1.4 | -1.13 | -0.84 | -0.76 | -0.71 | -1.53 | -1.3 |
EBITDA | n/a | -12.11M | -12.09M | -7.6M | -5.62M | -4.63M | -6.23M | -7.43M | -8.36M | -10.62M | -12.54M | -10.01M | -7.16M | -7.05M | -6.63M | -11.25M | -7.93M |
EBIT | n/a | -12.16M | -12.15M | -7.66M | -5.68M | -4.69M | -6.33M | -7.53M | -8.42M | -10.69M | -12.6M | -10.06M | -7.22M | -7.12M | -6.69M | -11.31M | -8M |
Depreciation & Amortization | n/a | 58K | 57K | 57K | 57K | 57K | 100K | 100K | 58K | 65K | 55K | 56K | 60K | 62K | 61K | 63K | 64K |